Nerve root injuries in patients with chronic low back pain

Orthopedic Clinics of North America

Volumn 34, Issue 2, 2003, Pages 221-230

  Brisby, Helena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; DYNORPHIN CONVERTING ENZYME; INTERLEUKIN 8; NEUROFILAMENT PROTEIN; PROTEIN S 100; SOMATOSTATIN; SUBSTANCE P; SUBSTANCE P ENDOPEPTIDASE; TRYPTOPHAN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

CHRONIC LOW BACK PAIN; CHRONIC PAIN; HUMAN; INFLAMMATION; LOW BACK PAIN; MECHANICAL STRESS; NERVE CELL EXCITABILITY; NERVE REGENERATION; NERVE ROOT COMPRESSION; NERVE ROOT INJURY; NEUROANATOMY; PRIORITY JOURNAL; REVIEW; SPINAL GANGLION; SYMPTOMATOLOGY;

EID: 0038678184     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-5898(03)00002-6     Document Type: Review

References (106)

1. Allan DB, Waddell G. An historical perspective on low back pain and disability. Acta Orthop Scand Suppl 1989;234:1-23.
2. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999;354:581-5.
3. Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363-70.
4. Cavanaugh JM, Ozaktay AC, Yamashita T, Avramov A, Getchell TV, King AI. Mechanisms of low back pain: a neurophysiologic and neuroanatomic study. Clin Orthop 1997;335:166-80.
5. Mackenzie RA, Burke D, Skuse NF, Lethlean AK. Fibre function and perception during cutaneous nerve block. Proc Aust Assoc Neurol 1975;12:65-73.
6. Ohtori S, Takahashi Y, Takahashi K, Yamagata M, Chiba T, Tanaka K, et al. Sensory innervation of the dorsal portion of the lumbar intervertebral disc in rats. Spine 1999;24:2295-9.
7. Woolf CJ. The pathophysiology of peripheral neuropathic pain-abnormal peripheral input and abnormal central processing. Acta Neurochir Suppl (Wien) 1993;58:125-30.
8. Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes. Neurology 2002;59(Suppl 2):S2-7.
9. Petersen-Felix S, Curatolo M. Neuroplasticity - an important factor in acute and chronic pain. Swiss Med Wkly 2002;132:273-8.
10. Marszalek JR, Williamson TL, Lee MK, Xu Z, Hoffman PN, Becher MW, et al. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. J Cell Biol 1996;135:711-24.
11. Bunge RP. Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Curr Opin Neurobiol 1993;3:805-9.
12. Bartosik-Psujek H, Stelmasiak Z. Biochemical markers of damage of the central nervous system in multiple sclerosis. Ann Univ Mariae Curie Sklodowska [Med] 2001;56:389-92.
13. Rosengren LE, Karlsson J-E, Karlsson J-O, Persson L, Wikkelso C. Patients with amyopotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 1996;67:2017-20.
14. Ahmed FA, Ingoglia NA, Sharma SC. Axon resealing following transection takes longer in central axons than in peripheral axons: implications for axonal regeneration. Exp Neurol 2001;167:451-5.
15. Byröd G, Olmarker K, Konno S, Larsson K, Takahashi K, Rydevik B. A rapid transport route between the epidural space and the intraneural capillaries of the nerve roots. Spine 1995;20:138-43.
16. Byrod G, Rydevik B, Johansson BR, Olmarker K. Transport of epidurally applied horseradish peroxidase to the endoneurial space of dorsal root ganglia: a light and electron microscopic study. J Peripher Nerv Syst 2000;5:218-26.
17. Byröd G, Otani K, Brisby H, Rydevik B, Olmarker K. Methylprednisolone reduces the early vascular permeability increase in spinal nerve roots induced by epidural nucleus pulposus application. J Orthop Res 2000;18:983-7.
18. Byröd G, Bergström G, Rydevik B, Olmarker K. Early hyperemia in spinal nerve roots induced by epidural application of autologous nucleus pulposus. Thesis. Göteborg, Sweden: Göteborg University; 2000.
19. Olmarker K, Rydevik B, Holm S. Edema formation in spinal nerve roots induced by experimental, graded compression. An experimental study on the pig cauda equina with special reference to differences in effects between rapid and slow onset of compression. Spine 1989;14:569-73.
20. Olmarker K, Rydevik B, Hansson T, Holm S. Compression-induced changes of the nutritional supply to the porcine cauda equina. J Spinal Disord 1990;3:25-9.
21. Rydevik B, Lundborg G. Permeability of intraneural microvessels and perineurium following acute, graded nerve compression. Scand J Plast Reconstr Surg 1977;11:179-87.
22. Rydevik B, Lundborg G, Bagge U. Effects of graded compression on intraneural blood flow. J Hand Surg 1981;6:3-12.
23. Rydevik B, Nordborg C. Changes in nerve function and nerve fibre structure induced by acute, graded compression. J Neurol Neurosurg Psychiatry 1980;43:1070-82.
24. Skouen JS, Larsen JL, Vollset SE. Cerebrospinal fluid proteins as indicators of nerve root compression in patients with sciatica caused by disc herniation. Spine 1993;18:72-9.
25. Olmarker K, Holm S, Rydevuik B. Importance of compression onset rate for the degree of impairment of impulse propagation in experimental compression injury of the pig cauda equina. Spine 1990;15:416-9.
26. Spencer DL, Miller JAA, Bertolini JE. The effects of intervertebral disc narrowing on the contact force between the nerve root and a simulated disc protrusion. Spine 1984;9:422-6.
27. Garfin SR, Rydevik BL, Brown RA. Compressive neuropathy of spinal nerve roots. A mechanical or biological problem? Spine 1991;16:162-6.
28. Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am 1991;22:181-7.
29. Olmarker K, Myers RR. Pathogenesis of sciatic pain: role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain 1998;78:99-105.
30. Rydevik B, Brown MD, Lundborg G. Pathoanatomy and pathophysiology of nerve root compression. Spine 1984;9:7-15.
31. Haig AJ, Weiner JB, Tew J, Quint D, Yamakawa K. The relation among spinal geometry on MRI, paraspinal electromyographic abnormalities, and age in persons referred for electrodiagnostic testing of low back symptoms. Spine 2002;27:1918-25.
32. Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 1993;18:1425-32.
33. Parris WC, Kambam JR, Naukam RJ, Rama Sastry BV. Immunoreactive substance P is decreased in saliva of patients with chronic back pain syndromes. Anesth Analg 1990;70:63-7.
34. Yabuki S, Igarashi T, Kikuchi S. Application of nucleus pulposus to the nerve root simultaneously reduces blood flow in dorsal root ganglion and corresponding hindpaw in the rat. Spine 2000;25:1471-6.
35. Olmarker K, Nordborg C, Larsson K, Rydevik B. Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine 1996;21:411-4.
36. Anzai H, Hamba M, Onda A, Konno S, Kikuchi S. Epidural application of nucleus pulposus enhances nociresponses of rat dorsal horn neurons. Spine 2002;27:E50-5.
37. Takebayashi T, Cavanaugh JM, Cuneyt Ozaktay A, Kallakuri S, Chen C. Effect of nucleus pulposus on the neural activity of dorsal root ganglion. Spine 2001;26:940-5.
38. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS. mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine 2002;27:911-7.
39. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine 2002;27:1402-7.
40. Igarashi T, Kikuchi S, Shubayev V, Myers RR. 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 2000;25:2975-80.
41. Kang JD, Georgescu HI, McIntyre-Larkin L, Stevanovic-Racic M, Donaldson WF, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6 and prostaglandin E2. Spine 1996;21:271-7.
42. Olmarker K, Larsson K. Tumor necrosis factor α and nucleus-pulposus-induced nerve root injury. Spine 1998;23:2538-44.
43. Rand N, Reichert F, Floman Y, Rotshenker S. Murine nucleus pulposus-derived cells secrete interleukins-1-β, -6, and -10 and granolulocyte-macrophage colony-stimulating factor in cell culture. Spine 1997;22:2598-602.
44. Takahashi H, Sugaro T, Okazima Y, Motegi M, Okada Y, Kakiuchi T. Inflammatory cytokines in the herniated disc of the lumbar spine. Spine 1996;21:218-24.
45. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002;84:196-201.
46. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996;73:625-9.
47. Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain 1995;118:869-78.
48. Wagner R, Myers RR. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 1996;7:2897-901.
49. Korhonen T, Karpainene A, Malmivaara A, Paimela L, Kyllönen E, Lindgren K-A, et al. Treatment of sciatica with infliximab, a monoclonal humanized chiamaeric antibody against TNFα Presented at 29th Annual Meeting of International Society for Study of the Lumbar Pain (ISSLS). Cleveland, OH, May 14-18, 2002.
50. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 2001;26:863-9.
51. Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 1999;276(2, Pt 1):G315-21.
52. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
53. Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int 1996;29:97-110.
54. Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling. Crit Care Med 2000;28(4, Suppl): N37-52.
55. Shrager P, Custer AW, Kazarinova K, Rasband MN, Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J Neurophysiol 1998;79:529-36.
56. Anbar M, Gratt BM. Role of nitric oxide in the physiopathology of pain. J Pain Symptom Manage 1997;14:225-54.
57. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SL. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992;89:6711-5.
58. Brisby H, Byrod G, Olmarker K, Miller VM, Aoki Y, Rydevik B. Nitric oxide as a mediator of nucleus pulposus-induced effects on spinal nerve roots. J Orthop Res 2000;18:815-20.
59. Kawakami M, Matsumoto T, Kuribayashi K, Tamaki T. mRNA expression of interleukins, phospholipase A2, and nitric oxide synthase in the nerve root and dorsal root ganglion induced by autologous nucleus pulposus in the rat. J Orthop Res 1999;17:941-6.
60. Inoue T, Mashimo T, Shibata M, Shibuta S, Yoshiya I. Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model. Brain Res 1998;792:263-70.
61. Obata K, Tsujino H, Yamanaka H, Yi D, Fukuoka T, Hashimoto N, et al. Expression of neurotrophic factors in the dorsal root ganglion in a rat model of lumbar disc herniation. Pain 2002;99:121-32.
62. Leffler A, Cummins TR, Dib-Hajj SD, Hormuzdiar WN, Black JA, Waxman SG. GDNF and NGF reverse changes in repriming of TTX-sensitive Na(+) currents following axotomy of dorsal root ganglion neurons. J Neurophysiol 2002;88:650-8.
63. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain 2000;89:7-18.
64. Grachev ID, Fredrickson BE, Apkarian AV. Brain chemistry reflects dual states of pain and anxiety in chronic low back pain. J Neural Transm 2002;109:1309-34.
65. Waxman SG, Cummins TR, Dib-Hajj SD, Black JA. Voltage-gated sodium channels and the molecular pathogenesis of pain: a review. J Rehabil Res Dev 2000;37:517-28.
66. Tanaka M, Cummins TR, Ishikawa K, Dib-Hajj SD, Black JA, Waxman SG. SNS Na + channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model. Neuroreport 1998;9:967-72.
67. Waxman SG, Kocsis JD, Black JA. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 1994;72:466-70.
68. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc Natl Acad Sci USA 1999;96:7635-9.
69. Comefjord M, Byrod G, Brisby H, Rydevik B. A long-term (4- to 12-year) follow-up study of surgical treatment of lumbar spinal stenosis. Eur Spine J 2000;9:563-70.
70. McGregor AH, Hughes SP. The evaluation of the surgical management of nerve root compression in patients with low back pain. Part 1. The assessment of outcome. Spine 2002;27:1465-70.
71. Guigui P, Benoist M, Delecourt C, Delhoume J, Deburge A. Motor deficit in lumbar spinal stenosis: a retrospective study of a series of 50 patients. J Spinal Disord 1998;11:283-8.
72. Jonsson B, Stromqvist B. Motor affliction of the L5 nerve root in lumbar nerve root compression syndromes. Spine 1995;20:2012-5.
73. Jonsson B, Stromqvist B. Neurologic signs in lumbar disc herniation. Preoperative affliction and postoperative recovery in 150 cases. Acta Orthop Scand 1996;67:466-9.
74. Postacchini F, Giannicola G, Cinotti G. Recovery of motor deficits after microdiscectomy for lumbar disc herniation. J Bone Joint Surg Br 2002;84:1040-5.
75. Matsui H, Kanamori M, Kawaguchi Y, Kitagawa H, Nakamura H, Tsuji H. Clinical and electrophysiologic characteristics of compressed lumbar nerve roots. Spine 1997;22:2100-5.
76. Fritzell P, Hagg O, Wessberg P, Nordwall A. The Swedish Lumbar Spine Study Group. Chronic low back pain and fusion: a comparison of three surgical techniques - a prospective multicenter randomized study. Spine 2002;27:1131-41.
77. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 1997;350:178-81.
78. Melrose J, Roberts S, Smith S, Menage J, Ghosh P. Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine 2002;27:1278-85.
79. Coskun E, Suzer T, Topuz O, Zencir M, Pakdemirli E, Tahta K. Relationships between epidural fibrosis, pain, disability, and psychological factors after lumbar disc surgery. Eur Spine J 2000;9:218-23.
80. Richter HP, Kast E, Tomczak R, Besenfelder W, Gaus W. Results of applying ADCON-L gel after lumbar discectomy: the German ADCON-L study. J Neurosurg 2001;95(2, Suppl):179-89.
81. BenDebba M, van Alphen HA, Long DM. Association between peridural scar and activity-related pain after lumbar discectomy. Neurol Res 1999;21(Suppl 1): S37-42.
82. de Tribolet N, Porchet F, Lutz TW, Gratzl O, Brotchi J, van Alphen HA, et al. Clinical assessment of a novel antiadhesion barrier gel: prospective, randomized, multicenter, clinical trial of ADCON-L to inhibit postoperative peridural fibrosis and related symptoms after lumbar discectomy. Am J Orthop 1998;27:111-20.
83. Maroon JC, Abla A, Bost J. Association between peridural scar and persistent low back pain after lumbar discectomy. Neurol Res 1999;21(Suppl 1): S43-6.
84. Skouen JS, Larsen JL, Vollset E, Gronning M. Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation. Eur Spine J 1994;3:107-11.
85. Brisby H, Olmarker K, Rosengren L, Cederlund CG, Rydevik B. Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica. Spine 1999;24:742-6.
86. Gårseth M, Sonnewald U, White LR, Rod M, Nygaard O, Zwart JA. Metabolic changes in the cerebrospinal fluid of patients with lumbar disc herniation or spinal stenosis. J Neurosci Res 2002;69(Sept. 1):692-5.
87. Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 2002;11:62-6.
88. Markus A, Patel T, Snider W. Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002;12:523-31.
89. Zhong J, Dietzel ID, Wahle P, Kopf M, Heumann R. Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J Neurosci 1999;19:4305-13.
90. Bomze HM, Bulsara KR, Iskandar BJ, Caroni P, Skene JH. Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons. Nat Neurosci 2001;4:38-43.
91. Snider WD, Zhou FQ, Zhong J, Markus A. Signaling the pathway to regeneration. Neuron 2002;35:13-6.
92. Neumann S, Bradke F, Tessier-Lavigne M, Basbaum Al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 2002;34:885-93.
93. Qiu J, Cai D, Dai H, McAtee M, Hoffman PN, Bregman BS, et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 2002;34:895-903.
94. Lindh C, Thomwall M, Hansen AC, Post C, Gordh T, Ordeberg G, et al. Neuropeptide-converting enzymes in cerebrospinal fluid: activities increased in pain from herniated lumbar disc, but not from coxarthrosis. Acta Orthop Scand 1996;67:189-92.
95. Hyyppa MT, Alaranta H, Lahtela K, Nykvist F, Hurme M, Nyberg F, et al. Neuropeptide converting enzyme activities in CSF of low back pain patients. Pain 1990;43:163-8.
96. Parris WC, Sastry BV, Kambam JR, Naukam RJ, Johnson BW. Immunoreactive substance P in human saliva. A possible marker of chronic pain. Ann N Y Acad Sci 1993;694:308-10.
97. Lindh C, Liu Z, Lyrenas S, Ordeberg G, Nyberg F. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in pafients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997;26:468-72.
98. Urban BJ, France RD, Bissette G, Spielman FJ, Nemeroff CB. Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in chronic pain patients. Pain 1988;33:169-72.
99. Cramer H, Rosler N, Rissler K, Gagnieu MC, Renaud B. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. Neuropeptides 1988;12:119-24.
100. Grönblad M, Lukinmaa A, Jolkkonen J, Schugk P, Seitsalo S, Korkala O, et al. Straight leg raising test and lumbar cerebrospinal fluid levels of vasoactive intestinal polypeptide and somatostatin in patients with low back pain. Spine 1994;19:1462-6.
101. Milovanovic DD, Stevanovic HL, Pavlovic J. Plasma tryptophan levels in the patients with cervicobrachial and lumbosacral pain syndromes. Adv Exp Med Biol 1996;398:107-11.
102. Cameron BM, VanderPutten DM, Merril CR. Preliminary study of an increase of a plasma apolipoprotein E variant associated with peripheral nerve damage. A finding in patients with chronic spinal pain. Spine 1995;20:581-9.
103. Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. J Neurol Sci 1997;145:33-9.
104. Olmarker K, Blomquist MS, Strömberg MS, Nannmark U, Thomsen P, Rydevik B. Inflammatogenic properties of nucleus pulposus. Spine 1995;6:665-9.
105. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997;120:2149-57.
106. Rydevik BL, Pedowitz RA, Hargens AR, Swenson MR, Myers RR, Garfin SR. Effects of acute, graded compression on spinal nerve root function and structure. An experimental study of the pig cauda equina. Spine 1991;16:487-93.